Charles Schwab Investment Management Inc Protara Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 15,000 shares of TARA stock, worth $45,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000Holding current value
$45,600% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding TARA
# of Institutions
65Shares Held
28.4MCall Options Held
365KPut Options Held
108K-
Janus Henderson Group PLC London, X03.79MShares$11.5 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.4MShares$10.3 Million0.3% of portfolio
-
Blackstone Inc New York, NY1.74MShares$5.3 Million0.03% of portfolio
-
Opaleye Management Inc. Boston, MA1.73MShares$5.26 Million2.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA1.67MShares$5.07 Million12.25% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $34.3M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...